Euclea crispa
Euclea crispa · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Euclea crispa is a noteworthy botanical species that has gained scientific interest due to its diverse medicinal potential. Research focusing on the hexane extract of its leaves has revealed significant biological activities, including anti-HIV, antifeedant, and anti-flu properties. Specifically, the plant demonstrates powerful anticarcinomic capabilities, showing promise in the management of conditions such as breast cancer, cancer, and ovarian cancer. Chemical analyses of the plant have identified key compounds, including 6-(4,6-dioxo-1,4,5,6-tetrahydropyrimidin-2-yl-amino)hexanoic acid trifluoroacetate, hydrocortisone acetate, and phenyl glucuronide. These findings underscore the importance of further exploring this species for its therapeutic contributions to modern pharmacology.
- Synonyms
- Celastrus Crispus
- Common names
- Not available
- Family
- Ebenaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Euclea crispa is a versatile shrub known by several different regional names. It is most frequently referred to as the Blue Guarri or the Blue Gwarrie depending on local spelling preferences. Some enthusiasts also identify the species as the Blue Leaved Euclea to highlight its distinctive foliage. In certain areas, it may be called Bloughwarrie or Bosghwarrie, reflecting its diverse linguistic connections. Understanding these various common names is essential for anyone studying this unique plant.
Sources: Catalogue of Life (COL)
Synonyms
Euclea crispa is a botanical species that is frequently identified by its alternative scientific name, Celastrus crispus. This taxonomic synonym reflects the evolving nature of plant classification and historical naming conventions. Researchers and botanists often encounter both terms when studying the plant's specific characteristics and distribution. Understanding these nomenclature shifts is essential for ensuring accuracy in scientific literature and field identification. Consequently, recognizing Celastrus crispus as a synonym helps maintain clarity within the broader study of plant relationships.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Euclea crispa is a distinct botanical organism belonging to the kingdom Plantae. Within this vast realm, it is specifically classified under the class Equisetopsida. The plant further belongs to the order Ericales, showcasing its unique evolutionary placement. It is a member of the genus Euclea, which helps define its specific morphological characteristics. Finally, it is categorized under the family Ebenaceae, anchoring its identity within the wider plant community.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Ebenaceae |
| Genus | Euclea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Euclea crispa is a plant species with a widespread distribution throughout the African continent. It is particularly prevalent across the diverse landscapes of South Tropical Africa. Within this region, the species can be found flourishing in the territory of Angola. Its presence extends further into the neighboring nations of Malawi and Mozambique. Additionally, the plant is a common feature of the natural environments found in Zambia and Zimbabwe.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Euclea crispa is a versatile plant characterized by its distinct shrub growth form. As a self-supporting species, it maintains a sturdy structure as it develops within its natural habitat. The height of this plant can vary significantly, ranging from a diminutive 0.3 m to a substantial 6.5 m. In some environments, it may even reach a maximum height of 9 m. This wide range of sizes allows the species to adapt effectively to diverse ecological niches.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Euclea crispa is a South African medicinal plant belonging to the Ebenaceae family that holds significant therapeutic potential. Recent chemical fingerprinting of its leaf extracts has successfully identified several key natural compounds within the plant. Notably, the research highlights that Euclea crispa contains hydrocortisone acetate and phenyl glucuronide. Through molecular docking analysis, these specific constituents demonstrated promising inhibitory activities against the HER2 signaling pathway. Such findings suggest that these compounds could eventually serve as the foundation for developing new pharmaceutical agents to combat various cancers.
Conditions
Euclea crispa contains natural phytocompounds that may serve as potential inhibitors for the HER2 signaling pathway. By targeting HER2, these extracts offer a possible therapeutic approach for treating breast cancer and ovarian cancer. The plant's bioactive compounds show promise in addressing the progression of various types of cancer. Research indicates that these leaf extracts can be developed into new medicinal agents to manage cancer and its associated complications. Consequently, Euclea crispa holds significant potential for the treatment of cancer through its specific inhibitory activities.
Preparations
Euclea crispa leaves were specifically prepared as a hexane extract for this scientific investigation. This particular extraction method was utilized to evaluate the potential of the plant to inhibit the human epidermal growth factor receptor 2 signaling pathway. By using a hexane extract, researchers were able to conduct chemical fingerprinting to identify various natural compounds within the plant material. The study subsequently used molecular docking to analyze the inhibitory activities of the substances found within this specific extract. Ultimately, the hexane extract of Euclea crispa provided the necessary compounds for screening as potential therapeutic agents against cancer.
Parts used
Euclea crispa is a medicinal plant belonging to the Ebenaceae family that holds significant therapeutic promise in South Africa. Recent research has focused specifically on the leaf of this species to identify natural compounds capable of targeting cancer progression. By utilizing a hexane extract from these leaves, scientists have been able to screen for potential inhibitors against the human epidermal growth factor receptor 2 (HER2) signaling pathway. Molecular docking analysis revealed that several specific compounds within the leaf extract demonstrate strong inhibitory activities against this key cancer target. Consequently, these findings suggest that the bioactive constituents found in Euclea crispa leaves could serve as the foundation for developing novel therapeutic agents against breast and ovarian cancers.